Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H12O2 |
Molecular Weight | 116.1583 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C)(C)C(O)=O
InChI
InChIKey=VUAXHMVRKOTJKP-UHFFFAOYSA-N
InChI=1S/C6H12O2/c1-4-6(2,3)5(7)8/h4H2,1-3H3,(H,7,8)
Molecular Formula | C6H12O2 |
Molecular Weight | 116.1583 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 02:08:32 UTC 2023
by
admin
on
Sat Dec 16 02:08:32 UTC 2023
|
Record UNII |
AY606CN05O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
746120
Created by
admin on Sat Dec 16 02:08:32 UTC 2023 , Edited by admin on Sat Dec 16 02:08:32 UTC 2023
|
||
|
FDA ORPHAN DRUG |
751020
Created by
admin on Sat Dec 16 02:08:32 UTC 2023 , Edited by admin on Sat Dec 16 02:08:32 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
595-37-9
Created by
admin on Sat Dec 16 02:08:32 UTC 2023 , Edited by admin on Sat Dec 16 02:08:32 UTC 2023
|
PRIMARY | |||
|
741804
Created by
admin on Sat Dec 16 02:08:32 UTC 2023 , Edited by admin on Sat Dec 16 02:08:32 UTC 2023
|
PRIMARY | |||
|
C190420
Created by
admin on Sat Dec 16 02:08:32 UTC 2023 , Edited by admin on Sat Dec 16 02:08:32 UTC 2023
|
PRIMARY | |||
|
209-865-0
Created by
admin on Sat Dec 16 02:08:32 UTC 2023 , Edited by admin on Sat Dec 16 02:08:32 UTC 2023
|
PRIMARY | |||
|
AY606CN05O
Created by
admin on Sat Dec 16 02:08:32 UTC 2023 , Edited by admin on Sat Dec 16 02:08:32 UTC 2023
|
PRIMARY | |||
|
38649
Created by
admin on Sat Dec 16 02:08:32 UTC 2023 , Edited by admin on Sat Dec 16 02:08:32 UTC 2023
|
PRIMARY | |||
|
16045
Created by
admin on Sat Dec 16 02:08:32 UTC 2023 , Edited by admin on Sat Dec 16 02:08:32 UTC 2023
|
PRIMARY | |||
|
DTXSID0032811
Created by
admin on Sat Dec 16 02:08:32 UTC 2023 , Edited by admin on Sat Dec 16 02:08:32 UTC 2023
|
PRIMARY | |||
|
12144
Created by
admin on Sat Dec 16 02:08:32 UTC 2023 , Edited by admin on Sat Dec 16 02:08:32 UTC 2023
|
PRIMARY | |||
|
100000126089
Created by
admin on Sat Dec 16 02:08:32 UTC 2023 , Edited by admin on Sat Dec 16 02:08:32 UTC 2023
|
PRIMARY | |||
|
SUB33307
Created by
admin on Sat Dec 16 02:08:32 UTC 2023 , Edited by admin on Sat Dec 16 02:08:32 UTC 2023
|
PRIMARY | |||
|
11684
Created by
admin on Sat Dec 16 02:08:32 UTC 2023 , Edited by admin on Sat Dec 16 02:08:32 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
treatment of propionic acidemia (PA) and methylmalonic acidemia (MMA)
|